BioAsia 2026: Telangana Leads TechBio Revolution with AI and Healthcare Innovations

February 17, 2026
BioAsia 2026: Telangana Leads TechBio Revolution with AI and Healthcare Innovations
  • Plans to shift from supply-led manufacturing to solution-driven leadership by building talent in mRNA, gene editing, and AI-driven drug discovery, while boosting Hyderabad’s role in medical tourism.

  • The event aims to unite researchers, entrepreneurs, investors, and policymakers to accelerate the TechBio revolution and tackle major global health challenges.

  • The opening ceremony was led by the Telangana Chief Minister, with Prof. Bruce L. Levine receiving the Genome Valley Excellence Award for cancer gene therapy.

  • Inauguration and awards highlight Telangana’s leadership in life sciences, honoring Levine for cancer gene therapy work during the opening ceremony.

  • BioAsia 2026, Asia’s leading life sciences and health tech forum, opened in Hyderabad as its 23rd edition, with a focus on AI, automation, and data science to drive the next wave of healthcare innovation.

  • More than 175 exhibitors across pharmaceuticals, biotechnology, medtech, digital health, and advanced manufacturing are taking part, underscoring a broad, cross-sector TechBio showcase.

  • Telangana highlights its strong policies, skilled human resources, and premier educational institutions as core strengths fueling growth in life sciences.

  • Telangana unveiled initiatives like the Young India Skills University and Telangana School of Life Sciences to build talent in mRNA technology, gene therapy, and AI.

  • Recent initiatives cited include Telangana Next-Gen Life Sciences Policy, Genome Valley expansion, launch of 1Bio, and multiple global capability centres in Hyderabad.

  • Ongoing collaborations among research institutions, corporates, startups, MSMEs, and government were emphasized to create a trusted, future-ready life sciences ecosystem in Telangana.

  • Telangana Rising 2047 envisions making Telangana a USD 1 trillion economy by 2034 and USD 3 trillion by 2047 through collaboration across research labs, industry, startups, MSMEs, and government.

  • Telangana Life Sciences Policy 2026-30 promotes cross-border collaboration, international capital, and translation of breakthroughs into healthcare solutions to position Telangana as a global life sciences hub.

Summary based on 12 sources


Get a daily email with more World News stories

More Stories